Durezol Approval History
FDA Approved: Yes (First approved June 23, 2008)
Brand name: Durezol
Generic name: difluprednate
Dosage form: Ophthalmic Emulsion
Company: Sirion Therapeutics, Inc.
Treatment for: Postoperative Ocular Inflammation
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.
Development History and FDA Approval Process for Durezol
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.